申请人:AbbVie Inc.
公开号:US20130303547A1
公开(公告)日:2013-11-14
This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions.
本发明涉及:(a) 公式I的化合物及其盐,这些化合物和盐在肝炎C病毒(HCV)抑制剂方面有用;(b) 用于制备这些化合物和盐的中间体;(c) 包含这些化合物和盐的药物组合物;以及(d) 使用这些化合物、盐和组合物的方法。